Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
Qilu Jianshen Granules (杞鹿健肾颗粒) is a Traditional Chinese Medicine (TCM) manufactured by Qilu Pharmaceutical. It is formulated to tonify the kidney, replenish essence, and strengthen the Yang energy. The preparation consists of several herbal and animal-derived ingredients, including Lycium fruit (Gouqizi), Deer antler glue (Lujiaojiao), Epimedium (Yinyanghuo), and Rehmannia (Shudihuang). It is clinically indicated for the treatment of kidney Yang deficiency, which manifests as soreness and weakness in the waist and knees, dizziness, tinnitus, mental fatigue, and cold extremities. As a granule formulation, it is administered orally and is regulated as a pharmaceutical product in China.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Follow clinical development from study design and recruitment through results.
Explore development by indication, patient population, and geography.
Trace asset ownership, licensing agreements, and commercial partnerships.
Explore the patent landscape and regulatory exclusivity around an asset.
Compare development programs by target, modality, and indication.
Connect source evidence and development news to your research questions.
See how Gosset can support your research on 杞鹿健肾颗粒.